Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

NCT06483074 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease on Dialysis
Peritoneal Dialysis Complication
Sodium-glucose Cotransporter-2 Inhibitor
Residual Kidney Function

Interventions

DRUG: Empagliflozin 10 MG

Sponsor

Chinese University of Hong Kong